Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...

University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to ...

These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

In this week's InnovationRx newsletter, federal judges halt Trump's cuts to NIH research payments, rural hospitals' ongoing ...

Drugmakers — major beneficiaries of NIH-backed university research — have been largely silence on the Trump administration's ...

President Donald Trump is pursuing changes at NIH that would result in ten of millions of dollars in funding cuts for Texas ...

The impact will be crippling to biomedical research in the U.S., and institutions will immediately face hard choices about ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

The FDA approved brentuximab vedotin (Adcetris) in combination with lenalidomide (Revlimid) and rituximab for relapsed or ...

Robert F. Kennedy Jr. (RFK Jr.) has been confirmed by the Senate as secretary of the Department of Health and Human Services (HHS). In this ...